GNTA Other: a negative outcome, -29.3%

On November 4, 2026, Genenta Science S.p.A. reached its Other. The result was a negative outcome, and the stock moved -29.3% in the window around the event. It had already run -15.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.